Skip to main content

Table 4 Estimated survival probabilities from diagnosis depending on patient ECOG PS, corticosteroid therapy use and age

From: Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

ECOG PS

Steroid therapy

Age (years)

Survival probability (%)

At 6 months

At 12 months

At 18 months

At 24 months

0

No

40

97

86

73

64

  

45

96

84

70

60

  

50

96

82

66

56

  

55

95

80

62

51

  

60

95

77

58

46

  

65

94

74

54

41

  

70

93

71

49

36

  

75

92

68

44

32

  

80

91

64

39

27

 

Yes

40

94

73

52

40

  

45

93

70

48

35

  

50

92

67

43

30

  

55

91

63

38

25

  

60

89

59

33

21

  

65

88

54

28

16

  

70

86

50

23

13

  

75

84

45

19

9

  

80

82

40

15

7

1

No

40

96

83

68

58

  

45

96

81

64

53

  

50

95

79

60

49

  

55

94

76

56

44

  

60

93

73

52

39

  

65

93

70

47

34

  

70

91

66

42

29

  

75

90

62

37

24

  

80

89

58

32

20

 

Yes

40

92

68

45

32

  

45

91

65

40

28

  

50

90

61

35

23

  

55

89

57

30

18

  

60

87

52

26

14

  

65

85

47

21

11

  

70

83

43

17

8

  

75

81

38

13

5

  

80

79

33

10

4

2

No

40

94

73

52

40

  

45

93

70

47

35

  

50

92

67

43

30

  

55

90

63

38

25

  

60

89

59

33

20

  

65

88

54

28

16

  

70

86

50

23

12

  

75

84

45

19

9

  

80

82

40

15

7

 

Yes

40

87

53

26

15

  

45

85

48

22

11

  

50

84

43

17

8

  

55

81

38

13

6

  

60

79

33

10

4

  

65

76

28

7

2

  

70

73

24

5

1

  

75

70

19

3

1

  

80

67

15

2

0